The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer's Disease Pathology

被引:19
|
作者
Jove, Mariona [1 ]
Mota-Martorell, Natalia [1 ]
Torres, Pascual [1 ]
Ayala, Victoria [1 ]
Portero-Otin, Manuel [1 ]
Ferrer, Isidro [2 ,3 ]
Pamplona, Reinald [1 ]
机构
[1] Lleida Univ UdL, Lleida Biomed Res Inst IRBLleida, Dept Expt Med, Lleida 25198, Spain
[2] Univ Barcelona, Bellvitge Univ Hosp, Dept Pathol & Expt Therapeut, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08907, Spain
[3] ISCIII, Ctr Biomed Res Neurodegenerat Dis CIBERNED, Madrid 28220, Spain
来源
LIFE-BASEL | 2021年 / 11卷 / 05期
关键词
aging; ATP synthase; energy metabolism; entorhinal cortex; lipoxidation-derived damage; mitochondrial dysfunction; neurodegeneration; oxidative damage; MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; ANTEROLATERAL ENTORHINAL CORTEX; GENE-EXPRESSION PROFILES; HUMAN BRAIN; OXIDATIVE STRESS; LIPID-PEROXIDATION; NEURODEGENERATIVE DISEASES; PROTEOMIC IDENTIFICATION; REGIONAL VULNERABILITY;
D O I
10.3390/life11050388
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Current shreds of evidence point to the entorhinal cortex (EC) as the origin of the Alzheimer's disease (AD) pathology in the cerebrum. Compared with other cortical areas, the neurons from this brain region possess an inherent selective vulnerability derived from particular oxidative stress conditions that favor increased mitochondrial molecular damage with early bioenergetic involvement. This alteration of energy metabolism is the starting point for subsequent changes in a multitude of cell mechanisms, leading to neuronal dysfunction and, ultimately, cell death. These events are induced by changes that come with age, creating the substrate for the alteration of several neuronal pathways that will evolve toward neurodegeneration and, consequently, the development of AD pathology. In this context, the present review will focus on description of the biological mechanisms that confer vulnerability specifically to neurons of the entorhinal cortex, the changes induced by the aging process in this brain region, and the alterations at the mitochondrial level as the earliest mechanism for the development of AD pathology. Current findings allow us to propose the existence of an altered allostatic mechanism at the entorhinal cortex whose core is made up of mitochondrial oxidative stress, lipid metabolism, and energy production, and which, in a positive loop, evolves to neurodegeneration, laying the basis for the onset and progression of AD pathology.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment
    Reiss, Allison B.
    Ahmed, Saba
    Dayaramani, Christopher
    Glass, Amy D.
    Gomolin, Irving H.
    Pinkhasov, Aaron
    Stecker, Mark M.
    Wisniewski, Thomas
    De Leon, Joshua
    EXPERIMENTAL GERONTOLOGY, 2022, 164
  • [22] Targeting the Prodromal Stage of Alzheimer’s Disease: Bioenergetic and Mitochondrial Opportunities
    Charles C. Caldwell
    Jia Yao
    Roberta Diaz Brinton
    Neurotherapeutics, 2015, 12 : 66 - 80
  • [23] Targeting the Prodromal Stage of Alzheimer's Disease: Bioenergetic and Mitochondrial Opportunities
    Caldwell, Charles C.
    Yao, Jia
    Brinton, Roberta Diaz
    NEUROTHERAPEUTICS, 2015, 12 (01) : 66 - 80
  • [24] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090
  • [25] Metabolomics and mitochondrial dysfunction in Alzheimer's disease
    Kim, Dong Hee
    Gim, Jeong-An
    Yoon, Dahye
    Kim, Suhkmann
    Kim, Heui-Soo
    GENES & GENOMICS, 2017, 39 (03) : 295 - 300
  • [26] Mitochondrial aging and dysfunction in Alzheimer's disease
    Sullivan, PG
    Brown, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (03): : 407 - 410
  • [27] Mitochondrial dysfunction in models of Alzheimer's disease
    Eckert, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 23 - 23
  • [28] Metabolomics and mitochondrial dysfunction in Alzheimer’s disease
    Dong Hee Kim
    Jeong-An Gim
    Dahye Yoon
    Suhkmann Kim
    Heui-Soo Kim
    Genes & Genomics, 2017, 39 : 295 - 300
  • [29] Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease
    Chris Cadonic
    Mohammad Golam Sabbir
    Benedict C. Albensi
    Molecular Neurobiology, 2016, 53 : 6078 - 6090
  • [30] Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer's Disease Model
    Aurora Nino, Sandra
    Morales-Martinez, Adriana
    Chi-Ahumada, Erika
    Carrizales, Leticia
    Salgado-Delgado, Roberto
    Perez-Severiano, Francisca
    Diaz-Cintra, Sofia
    Jimenez-Capdeville, Maria E.
    Zarazua, Sergio
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (01): : 323 - 336